# Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder

> **NCT06269627** · PHASE4 · RECRUITING · sponsor: **National Institute on Alcohol Abuse and Alcoholism (NIAAA)** · enrollment: 48 (estimated)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Acamprosate calcium
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06269627
- **Lead sponsor:** National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-07
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06269627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06269627, "Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT06269627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*